F

Sorrento Therapeutics, Inc. SRNE

$0.00 $0.00-50.00% OTC PK
Recommendation
Dividend Power Score
Day's Range
$0.00$0.00
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

SRNE Rating

Reward
Risk

SRNE Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

SRNE Company Overview

Sector

SRNE Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

SRNE Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

SRNE Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

SRNE Price History

Loading...
52-Week Range1% of range
Current
$0.00
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

SRNE Valuation

Market Cap
Market Cap Rank
#19,277
Enterprise Value
--
Price/Sales (TTM)
Price/Book (Q)

SRNE Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

SRNE Corporate Info

Phone Number
858 203 4100
Address
4955 Directors Place
San Diego, CA 92121
Country
Year Founded

SRNE Filings

Filing Date
Monday, August 14, 2023
Period Date
Friday, June 30, 2023
Next Filing
(est)

SRNE Headlines

There are no news to display.